189 related articles for article (PubMed ID: 37004703)
41. Intravenous lacosamide in clinical practice-Results from an independent registry.
Lang N; Lange M; Schmitt FC; Bös M; Weber Y; Evers S; Burghaus L; Kellinghaus C; Schubert-Bast S; Bösel J; Lammers T; Sabolek M; van Baalen A; Dziewas R; Kraft A; Ruf S; Stephani U
Seizure; 2016 Jul; 39():5-9. PubMed ID: 27161669
[TBL] [Abstract][Full Text] [Related]
42. Adjunctive lacosamide in clinical practice: sodium blockade with a difference?
Stephen LJ; Kelly K; Parker P; Brodie MJ
Epilepsy Behav; 2011 Nov; 22(3):499-504. PubMed ID: 21890421
[TBL] [Abstract][Full Text] [Related]
43. Lacosamide for uncontrolled primary generalized tonic-clonic seizures: An open-label pilot study with 59-week extension.
Wechsler RT; Yates SL; Messenheimer J; Leroy R; Beller C; Doty P
Epilepsy Res; 2017 Feb; 130():13-20. PubMed ID: 28086164
[TBL] [Abstract][Full Text] [Related]
44. The challenges of assessing effectiveness of lacosamide using electronic medical record databases.
Kalilani L; Halpern R; Seare J; Dedeken P
Epilepsy Behav; 2018 Aug; 85():195-199. PubMed ID: 30032807
[TBL] [Abstract][Full Text] [Related]
45. Efficacy and tolerability of lacosamide in the concomitant treatment of 130 patients under 16 years of age with refractory epilepsy: a prospective, open-label, observational, multicenter study in Spain.
Casas-Fernández C; Martínez-Bermejo A; Rufo-Campos M; Smeyers-Durá P; Herranz-Fernández JL; Ibáñez-Micó S; Campistol-Plana J; Alarcón-Martínez H; Campos-Castelló J
Drugs R D; 2012 Dec; 12(4):187-97. PubMed ID: 23193979
[TBL] [Abstract][Full Text] [Related]
46. Lacosamide as adjunctive therapy in treatment-resistant epilepsy in childhood.
Gulati P; Cannell P; Ghia T; Bint L; Walsh P; Ghosh S; Nagarajan L
J Paediatr Child Health; 2015 Aug; 51(8):794-7. PubMed ID: 25683595
[TBL] [Abstract][Full Text] [Related]
47. Lacosamide as adjunctive therapy for partial-onset seizures: a randomized controlled trial.
Chung S; Sperling MR; Biton V; Krauss G; Hebert D; Rudd GD; Doty P;
Epilepsia; 2010 Jun; 51(6):958-67. PubMed ID: 20132285
[TBL] [Abstract][Full Text] [Related]
48. Efficacy and safety of perampanel monotherapy in Chinese patients with focal-onset seizures: A single-center, prospective, real-world observational study.
Ma H; Zhu H; Chen F; Yang Y; Qu X; Xu H; Yang L; Zhang R
Epilepsia Open; 2023 Dec; 8(4):1474-1483. PubMed ID: 37661647
[TBL] [Abstract][Full Text] [Related]
49. Equipotency of lacosamide to levetiracetam in new onset focal epilepsy: A randomized controlled trial.
Jaiswal BK; Bhoi SK; Jha M; Samal P; Porey C
J Neurosci Rural Pract; 2023; 14(4):622-628. PubMed ID: 38059231
[TBL] [Abstract][Full Text] [Related]
50. Early add-on lacosamide in a real-life setting: results of the REALLY study.
Villanueva V; Garcés M; López-Gomáriz E; Serratosa JM; González-Giráldez B; Parra J; Rodríguez-Uranga J; Toledo M; López González FJ; Bermejo P; Giner P; Castillo A; Molins A; Campos D; Mauri JÁ; Muñoz R; Bonet M; Serrano-Castro P; del Villar A; Saiz-Díaz RA;
Clin Drug Investig; 2015 Feb; 35(2):121-31. PubMed ID: 25488477
[TBL] [Abstract][Full Text] [Related]
51. Safety, efficacy, and tolerability of lacosamide for the treatment of epilepsy in pediatric patients in Uygur, China.
Zhao T; Li HJ; Ma L; Feng J; Wang TT; Yu J; Sun L; Sun Y; Yu LH
Epilepsy Behav; 2021 Apr; 117():107814. PubMed ID: 33611102
[TBL] [Abstract][Full Text] [Related]
52. Efficacy and tolerability of lacosamide as an adjunctive therapy in children with refractory partial epilepsy.
Pasha I; Kamate M; Didagi SK
Pediatr Neurol; 2014 Oct; 51(4):509-14. PubMed ID: 25266613
[TBL] [Abstract][Full Text] [Related]
53. Long-term safety and efficacy in patients with uncontrolled partial-onset seizures treated with adjunctive lacosamide: results from a Phase III open-label extension trial.
Husain A; Chung S; Faught E; Isojarvi J; McShea C; Doty P
Epilepsia; 2012 Mar; 53(3):521-8. PubMed ID: 22372628
[TBL] [Abstract][Full Text] [Related]
54. Intravenous lacosamide in seizure emergencies: Observations from a hospitalized in-patient adult population.
d'Orsi G; Pascarella MG; Martino T; Carapelle E; Pacillo F; Di Claudio MT; Mancini D; Trivisano M; Avolio C; Specchio LM
Seizure; 2016 Nov; 42():20-28. PubMed ID: 27693808
[TBL] [Abstract][Full Text] [Related]
55. Twelve-Month Efficacy of Lacosamide Monotherapy at Maximal Dose and Tolerability for Epilepsy Treatment in Pediatric Patients: Real-World Clinical Experience.
Zhao T; Li HJ; Zhang HL; Yu J; Feng J; Wang TT; Sun Y; Yu LH
Pediatr Neurol; 2023 May; 142():23-30. PubMed ID: 36868054
[TBL] [Abstract][Full Text] [Related]
56. Lacosamide in patients with temporal lobe epilepsy: An observational multicentric open-label study.
Borzì G; Di Gennaro G; Schmitt FC; D'Aniello A; Mumoli L; Zummo L; Daniele O; Russo E; Gambardella A; Labate A
Epilepsy Behav; 2016 May; 58():111-4. PubMed ID: 27064831
[TBL] [Abstract][Full Text] [Related]
57. Lacosamide treatment of childhood refractory focal epilepsy: the first reported side effect in paediatric patients.
Yildiz EP; Ozkan MU; Bektas G; Uzunhan TA; Aydinli N; Caliskan M; Ozmen M
Childs Nerv Syst; 2017 Nov; 33(11):2023-2027. PubMed ID: 28884208
[TBL] [Abstract][Full Text] [Related]
58. Long-term efficacy and safety of lacosamide monotherapy in the treatment of partial-onset seizures: A multicenter evaluation.
Giráldez BG; Toledano R; García-Morales I; Gil-Nagel A; López-González FJ; Tortosa D; Ojeda J; Serratosa JM
Seizure; 2015 Jul; 29():119-22. PubMed ID: 26076854
[TBL] [Abstract][Full Text] [Related]
59. Safety, tolerability, and efficacy of brivaracetam as adjunctive therapy in patients with focal seizures, generalized onset seizures, or Unverricht-Lundborg disease: An open-label, long-term follow-up trial.
Ben-Menachem E; Baulac M; Hong SB; Cleveland JM; Reichel C; Schulz AL; Wagener G; Brandt C
Epilepsy Res; 2021 Feb; 170():106526. PubMed ID: 33461041
[TBL] [Abstract][Full Text] [Related]
60. Effectiveness and safety of perampanel as early add-on treatment in patients with epilepsy and focal seizures in the routine clinical practice: Spain prospective study (PERADON).
Abril Jaramillo J; Estévez María JC; Girón Úbeda JM; Vega López Ó; Calzado Rivas ME; Pérez Díaz H; García Martín G; Vila Herrero E; Chamorro-Muñoz M; Vázquez F; De la Fuente C; Redondo L; Peláez N; Santágueda P; Rodríguez Uranga JJ
Epilepsy Behav; 2020 Jan; 102():106655. PubMed ID: 31812902
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
